Unilever Boston Consulting Group Matrix
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Unilever Bundle
Unlock Strategic Clarity
Unilever’s BCG Matrix preview shows which brands are fueling growth, which are milking profits, and which need rethinking — a quick pulse on portfolio health you can use today. Want the full picture? Purchase the complete BCG Matrix for quadrant-by-quadrant placements, data-backed recommendations, and a ready-to-present Word report plus an Excel summary. Save time, cut through the noise, and get a practical roadmap for reallocating resources and prioritizing investments.
Stars
Dove (global beauty & skin)
Dove (global beauty & skin) sits as a Star for Unilever: high share while riding a premium, purpose-led wave across 150+ countries and anchored by the Real Beauty platform since 2004. Growth pockets in body wash, bars and skin routines keep ad dollars efficient; continuous product innovation and heavy media are required as rivals imitate. Keep investing — this engine can deliver larger cash flows.
Rexona/Sure (deodorants)
Category expanding in emerging markets, trading up to premium efficacy with deodorant volumes in several EMs rising about 6% in 2024; Rexona/Sure’s motion‑sense and clinical lines keep it front‑of‑shelf and have driven double‑digit share gains in key markets in 2024. Media and sampling remain critical to conversion. Competitors are loud, so distribution and innovation cadence can’t slow; keep the pedal down—it pays back.
Omo/Surf Excel (laundry in EM)
Laundry in Asia, Africa and LATAM is a high-growth EM segment where Omo/Surf Excel consistently own aisle share, driven by sachets, liquid formats and stain-tech upgrades that increase penetration and trade-up. Deep route-to-market networks provide a competitive moat but materially increase working capital and distribution costs. Unilever should invest to lock share ahead of category maturation and rising per‑capita laundry spend.
Lifebuoy (health & hygiene)
Lifebuoy sits as a Star in Unilever’s BCG matrix: post‑pandemic hand hygiene remains habit‑forming in developing markets, WHO/UNICEF estimate 3 billion people lack basic handwashing facilities, and handwashing cuts diarrheal disease by up to ~50% and respiratory infections ~20%. Lifebuoy’s trust, scale and school/community programs drive recruitment but require sustained education and product availability—purpose plus access to retain users and grow volume.
- Trust + scale: national campaigns and brand equity
- Programs: school/community outreach to convert habits
- Access: 3 billion lack facilities—distribution imperative
Paula’s Choice (prestige skin)
Paula’s Choice sits in Unilever’s BCG Stars: high-growth prestige skincare with a science-led edge and strong DTC foundation. Acquired by Unilever in 2021, the brand is still scaling globally while building counters and derm credibility. Performance marketing and NPD are cash-hungry but deliver strong ROI; feed it, runway’s long.
- science-led
- DTC-first
- scaling globally
- cash-hungry NPD/marketing
- long runway
Personal-care stars: premium-led growth, hygiene scale & DTC momentum
Dove, Rexona/Omo/Lifebuoy and Paula’s Choice rank as Stars: strong share, premium/innovation-led growth and high reinvestment needs. Dove spans 150+ countries; deodorant volumes rose ~6% in 2024 and Rexona/Sure saw double‑digit share gains in key markets. Lifebuoy leverages school/community programs amid WHO/UNICEF’s 3bn lacking handwashing facilities; Paula’s Choice (acquired 2021) is scaling DTC/prestige.
| Brand | 2024 signal | Reach | Capex/Marketing |
|---|---|---|---|
| Dove | Premium growth | 150+ countries | High |
| Rexona/Sure | +6% deodorant vols | Global | High |
| Lifebuoy | Habit formation | EM focus | Medium-High |
| Paula’s Choice | Prestige DTC scale | Global rollout | High |
What is included in the product
Detailed Word Document
Concise BCG Matrix for Unilever: identifies Stars, Cash Cows, Question Marks, Dogs with strategic moves to invest, hold, or divest.
Customizable Excel Spreadsheet
One-page Unilever BCG Matrix highlighting underperformers and stars to simplify strategy and speed executive decisions.
Cash Cows
Knorr
Knorr, present in 100+ markets, drives dependable cash from core bouillons, soups and meal-makers, showing mid-single-digit organic sales growth in 2024 and anchoring Unilever’s Foods portfolio.
Efficient supply chains, tiered pack-price architecture and steady promotions sustain velocity and market share while keeping gross-to-operating margins resilient.
Low capex intensity means incremental ops upgrades and SKU rationalization boost margins; strategy is to milk cash while protecting household penetration in mature markets.
Hellmann’s
Hellmanns sits in a steady dressings & condiments category with clear leadership in the US and beyond—holding roughly 28% of US retail mayonnaise share. Pricing power and culinary variants (light, flavored, vegan) sustain resilience and protect margins. Media can be surgical given strong brand memory, making Hellmanns a classic profit engine that funds Unilevers growth bets elsewhere.
Vaseline
Vaseline remains an iconic, trusted Unilever cash cow with broad distribution in petroleum jelly and lotions; the global petroleum jelly/lotion segment shows modest mid-single-digit growth (~2–4% CAGR). Its margin profile is solid and predictable, with brand-level sales estimated around $1bn annually and steady contribution to Unilever’s personal care cash flow. Light innovation and channel-pack tactics keep velocity high, delivering reliable cash with low drama.
Magnum
Magnum, launched in 1989, is Unilever's premium ice cream with strong brand desire and marked seasonal peaks; it's mature in many markets where price/mix does the heavy lifting while marketing remains efficient and innovation is mainly line-extension, delivering a steady cash stream.
Ben & Jerry’s
Ben & Jerry’s is a Unilever cash cow: loyal base and distinctive premium flavors support stable, profitable margins with limited heavy capex; retail sales historically around $1bn annually and continued mid-single-digit category growth in 2024 keeps top-line growth moderate while distribution is already dense.
- loyalty
- premium pricing
- stable margins
- moderate growth
- optimize vs chase volume
Cash & premium: 100+ mkts, 28% mayo, $1bn
Knorr: 100+ markets; mid-single-digit organic sales growth in 2024; core cash generator for Foods.
Hellmanns: ~28% US retail mayo share in 2024; pricing power and SKU variants sustain margins.
Vaseline: ~$1bn brand sales; 2024 category growth ~2–4% CAGR; low capex, predictable cash.
Ben & Jerry’s/Magnum: premium pricing, stable mid-single-digit growth in 2024; efficient marketing.
| Brand | 2024 metric | Margin role | Notes |
|---|---|---|---|
| Knorr | 100+ markets; mid-1%–5% growth | High | Core Foods cash |
| Hellmanns | ~28% US mayo share | High | Pricing/variants |
| Vaseline | ~$1bn sales | Stable | Low capex |
| Ben & Jerry’s | ~$1bn retail | Stable | Premium mix |
| Magnum | Seasonal premium | Stable | Price/mix |
Full Transparency, Always
Unilever BCG Matrix
The file you're previewing is the exact Unilever BCG Matrix report you'll receive after purchase—no watermarks, no placeholders, just the finished document. It’s formatted for clarity and built from market-backed analysis so you can use it straight away. After purchase the full file is delivered instantly to your inbox, editable, printable, and presentation-ready. No surprises—just a professional, strategy-ready asset for your planning.
Dogs
Low-share Oral Care (Signal/Pepsodent in mature markets)
In mature markets Colgate commands roughly 40% share and P&G brands around 15–20%, leaving Unilever Signal/Pepsodent with low single-digit positions (often <5%). The toothpaste category is mature, growing only about 1–2% CAGR in recent years (2022–24), so share gains require heavy spend. Customer-acquisition and trade-promo costs frequently push these lines to break-even after promotion. Such low-share lines are candidates for tight focus or market exit.
Tail-end local foods sub-brands
Tail-end local foods sub-brands at Unilever are small legacy SKUs crowding shelves; industry data shows tail SKUs often represent ~20% of assortment but generate <2% of sales, tying up an estimated 5–10% of working capital and increasing shelf fees; typical turnaround CAPEX rarely yields ROI, so recommended actions: trim SKUs, delist low-velocity items, or divest regional micro-brands.
Underperforming hair styling variants
Fragmented micro-lines that don’t clear thresholds often sit at SKU-level shares below 1%, requiring disproportionate support. Heavy promotion—discounts and off-invoice funding often exceeding 25%—is needed to maintain minimal share. They play little strategic role versus core shampoos/conditioners and should be rationalized to free the P&L.
Value ice cream stick-bars in saturated channels
Value ice cream stick-bars face heavy private-label pressure and minimal differentiation, leaving category pockets flat; Unilever ice cream sales were ~€6.5bn in 2023, highlighting scale but limited growth in value tiers. Price wars erode margin and brand equity; promo-dependent SKUs become cash traps. Recommend reducing exposure to saturated value channels and refocusing investment on premium, differentiated SKUs.
- private-label pressure
- little differentiation
- flat category pockets
- price wars crush margin
- promo-dependent cash trap
- reduce exposure, refocus premium
Non-core home cleaning SKUs with limited reach
Non-core home cleaning SKUs show niche formats with patchy distribution and low loyalty, delivering high complexity and minimal contribution to category margins; in a BCG Dogs position they drag portfolio efficiency. Complexity reduction programs typically outperform rescue plans for such SKUs, enabling reallocation to higher-return SKUs and channels. Prune decisively to free shelf space and reduce SKU-driven supply chain costs.
- Low distribution, low loyalty
- High complexity, low margin
- Complexity reduction > rescue
- Decisive pruning required
Cut low-share toothpaste and tail SKUs to free cash; promos sink margins
Dogs: low-share toothpaste (Unilever Signal/Pepsodent <5% 2024) in 1–2% category growth; promo costs push lines to break-even. Tail SKUs: ~20% assortment, <2% sales, tie 5–10% working capital. Value ice cream: scale but flat; promo-dependent margins. Non-core cleaners: low distribution, high complexity—prune to free cash.
| SKU | 2024 share | growth 2022–24 | impact |
|---|---|---|---|
| Toothpaste | <5% | 1–2% CAGR | break-even |
| Tail SKUs | ~20% assort. | — | <2% sales |
Question Marks
The Vegetarian Butcher
The Vegetarian Butcher, acquired by Unilever in 2018, sits as a Question Mark: plant-based is volatile but a structural growth bet with the global meat-alternatives market ~7.8bn in 2024 and strong projected demand. Brand equity is solid; scale and taste parity decide success. Needs heavy sampling, chef partnerships, and retail wins; invest with milestones and pivot if velocities stall.
Tatcha (prestige skin)
Tatcha is a luxe, high-growth prestige skin-care niche within Unilever, acquired in 2019 for up to $500 million and showing strong Asia–US appeal that supports premium price points. Distribution expansion and scaling hero SKUs (e.g., bestsellers like The Rice Polish) can unlock step-changes in top-line. This will require meaningful brand-building dollars and tight channel control to protect margin. Back the brand, but monitor profitability by market closely.
Dermalogica
Dermalogica sits as a Question Mark in Unilever’s BCG: a pro-grade, education-led skincare brand with strong authority but small share versus global giants; Unilever acquired Dermalogica in 2015 for about $1bn. The runway is in e‑commerce and clinic channels; scaling needs heavy investment in training, service and digital. Invest where partner ecosystems (salons, spas, e‑tail) are strongest.
Love Beauty and Planet
Love Beauty and Planet sits as a Question Mark in Unilever’s BCG: sustainability-first positioning resonates but the personal-care shelf is crowded; the brand is available in 70+ markets and showing distribution growth, yet scale and profitability remain uncertain. Awareness is decent while repeat purchase metrics are still developing, indicating trial-heavy demand. It needs distinctive functional or experiential benefits beyond green claims and should run test-and-learn pilots on claims, formats, and retailer mixes before scaling.
- Position: Question Mark
- Markets: 70+ markets distribution
- Focus: drive repeat via distinct benefits
- Action: test claims, formats, channels pre-scale
MURAD/Kate Somerville (select markets)
MURAD and Kate Somerville are strong brand stories with uneven global penetration; both sit as Question Marks within Unilever’s BCG matrix amid a high-growth skincare market (global skincare market ~179 billion USD in 2024). Capital needed for counters, clinicians, and performance media to close country-level share gaps; recommend pick 3–4 focus markets, prove unit economics, then scale rollouts.
- Focus markets: 3–4
- Capex: retail/clinics + media
- Metric: LTV:CAC >3
- 2024 market size: 179B USD
Test pilots, then scale: plant-based market $7.8bn, target LTV:CAC >3
Question Marks: Vegetarian Butcher (plant-based market ~$7.8bn 2024), Tatcha (acq 2019 up to $500m), Dermalogica (acq 2015 ~$1bn), Love Beauty & Planet (70+ markets), Murad/Kate Somerville — require focused investment, test-and-learn pilots, and LTV:CAC >3 to justify scale.
| Brand | 2024 metric | Key action |
|---|---|---|
| Vegetarian Butcher | $7.8bn market | sampling, retail wins |
| Tatcha | acq ≤$500m | premium channel control |
| Dermalogica | acq ~$1bn | e‑comm & clinics |